Pyrazinecarboxamide, 3,6-difluoro-(9CI) (356783-29-4)
This product(s) resides on a APICMO contract.
The ability to produce, synthesize and manufacture large quantities of Pyrazinecarboxamide, 3,6-difluoro-(9CI) (356783-29-4) with quality control system under CGMP manufacturing
Pyrazinecarboxamide, 3,6-difluoro-(9CI) (356783-29-4) Description
Pyrazinecarboxamide, 3,6-difluoro- (9CI) is an intermediate typically in the synthesis of Pyrazinecarboxamide, 3,6-difluoro- (9CI) commercially named Favipiravir, which is a unique viral RNA Polymerase inhibitor for the treatment of Influenza (potentially treat the novel coronavirus pneumonia), acting on viral genetic copying to prevent its reproduction. A practical and step-economic route to Favipiravir. The complete synthesis of favipiravir from 2-aminopyrazine.
Favipiravir was approved for marketing in Japan in March 2014 and used for antiviral treatment of influenza A and B. In addition to the influenza virus, the drug also showed good antiviral activity to a variety of RNA viruses, such as Ebola virus, sand virus, Bunia virus,
This product(s) resides on a APICMO contract. If you are viewing this page as a non-registered user, the price(s) displayed is List Price. To view your pricing, log in using your account number, or become a registered user by contacting one of our Customer Service teams. To place an order, contact APICMO Customer Service.
Pyrazinecarboxamide, 3,6-difluoro-(9CI) (356783-29-4) Specifications
|Chemical Name or Material||3,6-difluoropyrazine-2-carboxamide |
QC-770; AKOS005166867; FT-0686197
|Packaging||Aluminum Foil Bag|
|Molecular Weight (g/mol)||159.1|
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Bulk Ordering & Pricing:
Need larger quantities for your development, manufacturing or research applications?